MedTrace Logo

Procalcitonin as a Marker of Severity of Non-cystic Fibrosis Bronchiectasis in Children

NCT06352944 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-04-17

No results posted yet for this study

Summary

The aim of this study is to evaluate the role of procalcitonin in bronchoalveolar lavage as a biomarker for assessment of severity of non-CF bronchiectasis in children in correlation with other markers (functional and radiological severity )

Conditions

  • Non-cystic Fibrosis Bronchiectasis

Interventions

DIAGNOSTIC_TEST

procalcitonin

level of procalcitonin in bronchoalveolar lavage

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Yasser F abdelrahem, professor · Assiut University

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2025-07-31
Completion
2026-07-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06352944 on ClinicalTrials.gov